• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Finance

Synlogic reports Q3 results, including underwritten public offering of $21.0M and $2.5M milestone payment from Roche

November 11, 2023 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today reported financial results for the third quarter ended September 30, 2023, and provided […]

Pharma & Human Health

Mammalian cells may consume bacteria-killing viruses to promote cellular health

November 9, 2023 Microbiome Times

Bacteriophages are viruses that infect and kill bacteria, their natural hosts. But from a macromolecular viewpoint, phages can be viewed as nutritionally enriched packets of nucleotides wrapped in an amino acid shell. A study published […]

Pharma & Human Health

Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain

November 8, 2023 Microbiome Times

Health Canada authorizes functional claims that the probiotic strain DDS-1® “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adolescents and adults” The ‘gut-brain axis’ has become one of the most […]

Pharma & Human Health

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

November 7, 2023 Microbiome Times

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company developing Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, announced that the first patient has been treated as part of its Phase […]

Finance

Seres Therapeutics announces strategic restructuring and third quarter financial results including VOWST™ net sales

November 6, 2023 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, reported on November 2nd financial results for the third quarter ended September 30, 2023, including VOWST net sales of $7.6 million. Third quarter VOWST commercial […]

Pharma & Human Health

Atopic dermatitis: Viruses discovered as new therapy option

November 6, 2023 Microbiome Times

Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or […]

Pharma & Human Health

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors

November 6, 2023 Microbiome Times

A new probiotic-guided chimeric antigen receptor (CAR)-T platform uses engineered bacteria to infiltrate and produce synthetic antigen targets, enabling CAR-T cells to find, identify, and destroy tumor cells in situ, according to a new study. The […]

Editor's Choice

Using a novel computational approach, researchers confirm microbial diversity is wilder than ever.

October 30, 2023 Microbiome Times

A new study published online October 11, 2023 in Nature highlights the vast array of functional diversity of microbes through a novel approach to better understand microbial communities by looking at protein function within them. […]

Finance

Fonterra and APC Microbiome Ireland have announce the establishment of a new microbiome research centre

October 27, 2023 Microbiome Times

Senior Fonterra Managers Dr Mark Malone and Dr Shalome Bassett were in Ireland to launch the ‘Fonterra Microbiome Research Centre (Ireland)’, their new collaboration with APC Microbiome Ireland (APC), a world renowned SFI Research Centre […]

Finance

Lallemand Health Solutions is strengthening its strategic position in the microbiome field through CDMO operations

October 20, 2023 Microbiome Times

Lallemand Health Solutions is strengthening its strategic position in the microbiome field through contract development and manufacturing operations, with the launch of Expert’Biome™ CDMO by Lallemand. With Expert’Biome™, Lallemand Health Solutions aims to support partners […]

Pharma & Human Health

Scientists discover links between Alzheimer’s disease and gut microbiota

October 19, 2023 Microbiome Times

Researchers have discovered the link between the gut microbiota and Alzheimer’s disease. For the first time, researchers have found that Alzheimer’s symptoms can be transferred to a healthy young organism via the gut microbiota, confirming […]

Posts navigation

« 1 … 11 12 13 … 77 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
sign up

Sign up to the Microbiome Times newsletter